Scott Thomas Jackson
Chief Executive Officer, Celator Pharmaceuticals Inc.
Companies
- Mural Oncology plcBoard member Nov 7, 2023 to now1
- Spero Therapeutics, Inc.Board member Apr 23, 2020 to now2
- MACROGENICS INCBoard member Jan 25, 2017 to now3
- CRESCENT BIOPHARMA, INC.Board member Nov 28, 2018 to May 1, 20244
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Spero Therapeutics, Inc. SPRO85,000 shares5$96.9K at $1.14Jun 23, 2026
- MACROGENICS INC MGNX14,750 shares6$49.7K at $3.37May 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 23, 2026Granted 10,000 shares of Spero Therapeutics, Inc.5
- May 18, 2026Exercised options 3,750 shares of MACROGENICS INC6
- Jun 12, 2025Granted 20,000 shares of Spero Therapeutics, Inc.7
- May 20, 2025Exercised options 6,500 shares of MACROGENICS INC8
- May 29, 2024Granted 20,000 shares of Spero Therapeutics, Inc.9
- May 20, 2024Exercised options 4,500 shares of MACROGENICS INC10
- Oct 5, 2023Granted 20,000 shares of Spero Therapeutics, Inc.11
- Sep 15, 2022Granted 15,000 shares of Spero Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMural Oncology plc, Board member
- 2
- 3SEC EDGARMACROGENICS INC, Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 16, 2025
- 8SEC EDGARForm 4 filed May 22, 2025
- 9SEC EDGARForm 4 filed May 30, 2024
- 10SEC EDGARForm 4 filed May 22, 2024
- 11SEC EDGARForm 4 filed Oct 10, 2023
- 12SEC EDGARForm 4 filed Sep 19, 2022